Certified by Founder Lodge
Medicxi
United Kingdom - London
INVESTOR
1 Disclosed Funding Rounds $75,000,000
3 Participating Investments
-
Operating Status
Active
-
Last Funding Type
Seed
-
Company Type
For Profit
- Website
- Contact
- Social Links
medicxi is a Life Sciences venture capital firm, with offices in London, St. Helier (Jersey) and Geneva.
| Company | Date | Round | Raised |
|---|---|---|---|
 Fore Biotherapeutics |
August, 25 ,2023 | Series D | $75,000,000 |
 Curevo Vaccine |
March, 19 ,2025 | Series B | $110,000,000 |
 Altesa BioSciences, Inc. |
February, 20 ,2026 | Series B | $75,000,000 |
Cherry Ventures
Blue Bear Capital
Slow Ventures
Climate Capital
Eniac Ventures
Sigma360 | $17,000,000 | (Mar 11, 2026)
Verdant Impact | $3,000,000 | (Mar 11, 2026)
PactFi | $25,000,000 | (Mar 11, 2026)
Lux Aeterna | $10,000,000 | (Mar 11, 2026)
Axiom Trust Company | $11,800,000 | (Mar 11, 2026)
